Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115).
Raíra Mesquita MaschmannRafaela Gomes De JesusGustavo WerutskyTaiane Francieli RebelattoGeraldo QueirozSergio Daniel SimonJosé BinesCarlos Henrique Escosteguy BarriosDaniela Dornelles RosaPublished in: Breast cancer research and treatment (2022)
gov Identifier: NCT02663973, registered on January, 26th, 2016.